Northern Trust Corp Nemaura Medical Inc. Transaction History

Northern Trust Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.71 - $2.86 $6,238 - $25,127	8,786 Added 48.94%	26,737 $24,000
Q2 2021 Aug 13, 2021	SELL	$4.7 - $16.7 $309,683 - $1.1 Million	-65,890 Reduced 78.59%	17,951 $186,000
Q1 2021 May 12, 2021	BUY	$3.79 - $9.78 $5,302 - $13,682	1,399 Added 1.7%	83,841 $641,000
Q4 2020 Feb 11, 2021	BUY	$3.47 - $4.52 $2,633 - $3,430	759 Added 0.93%	82,442 $311,000
Q3 2020 Nov 16, 2020	BUY	$3.55 - $9.99 $19,269 - $54,225	5,428 Added 7.12%	81,683 $290,000
Q2 2020 Aug 14, 2020	BUY	$4.75 - $15.38 $362,211 - $1.17 Million	76,255 New	76,255 $705,000

Ticker NMRD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,102,900
Market Cap $723K
Description
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.